| Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia—Major Patients with the XmnI Polymorphism D Ghosh, A Panja, D Saha, U Banerjee, AK Datta, A Basu Genetic Testing and Molecular Biomarkers 25 (8), 563-570, 2021 | 6 | 2021 |
| Effect of deletions in the α-globin gene on the phenotype severity of β-thalassemia D Saha, PK Chowdhury, A Panja, D Pal, K Nayek, G Chakraborty, ... Hemoglobin 46 (2), 118-123, 2022 | 4 | 2022 |
| Burdwan University Thalassemia Severity (BUTS) Scoring System: A numerical Method For Defining the Clinicopathological status of Thalassaemia Patient A Basu, PK Chowdhury, T Chowdhuy, S Sadhukhan, PK Chakrabarti, ... medRxiv, 2021.05. 01.21256431, 2021 | 1 | 2021 |
| A family based whole exome sequence study to indentify modifier genes for phenotype heterogeneity between severe and non-severe thalassemia patients A BASU, D Saha, PK Chowdhury, D Pal, K Nayek, G Chakrabortye, ... Preprints, 2023 | | 2023 |
| Study on the Variation of the Interacting Genes among the Transfusion Dependent and Non Transfusion Dependent Thalassemia Subjects D Saha Bardhaman, 0 | | |
